Clinical Trials for Type 1 Diabetes Mellitus

FrexalimAB in Preservation of Endogenous insULIN Secretion Compared to Placebo in adUlts and Adolescents on Top of inSulin Therapy (FABULINUS)

NCT ID: NCT06111586

The FABULINUS trial is studying a new treatment called frexalimab for people with Type 1 Diabetes Mellitus (T1D) who are already using insulin. The goal of the trial is to see if frexalimab can hel...

A Phase III Study to Investigate if the Study Drug Diamyd Can Preserve Insulin Production and Improve Glycemic Control in Patients Newly Diagnosed With Type 1 Diabetes

NCT ID: NCT05018585

This clinical trial, called DIAGNODE-3, is testing a study drug named Diamyd to see if it can help preserve the body’s ability to produce insulin and improve blood sugar control in people who have ...

Treatment of Type 1 Diabetes With Anti-OX40L Bispecific With Anti-TNF Activity In a Single Nanobody® Molecule

NCT ID: NCT06812988

This clinical trial is studying a new treatment called SAR442970 for people with recently diagnosed Type 1 Diabetes (T1D), a condition where the body doesn’t produce enough insulin. The goal is to ...

Cardiometabolic Benefit of Reducing Iatrogenic Hyperinsulinemia Using Insulin Adjunctive Therapy in Type 1 Diabetes

NCT ID: NCT06609356

This clinical trial is looking to see how a specific treatment can help improve heart and blood sugar health in people with type 1 diabetes. The study will involve participants with type 1 diabetes...

Clinical Study to Evaluate the Impact of the Accu-Chek SmartGuide CGM Solution on the Mean Change in Time in Range Compared With Self-Monitoring of Blood Glucose in Participants With Type 1 and Type 2 Diabetes Mellitus

NCT ID: NCT06704672

This clinical trial is designed to study how well the Accu-Chek SmartGuide Continuous Glucose Monitoring (CGM) solution helps people with Type 1 or insulin-dependent Type 2 diabetes manage their bl...

Implementing the Spotlight AQ Platform in Adolescent/ Young Adult (16-25 Years Old) Type 1 Diabetics (T1D)

NCT ID: NCT06390371

This clinical trial is exploring a new tool called the Spotlight AQ survey to see if it can help improve diabetes management for young people aged 16 to 25 who have Type 1 Diabetes (T1D). The main ...

Societal Burden Associated With Type 1 Diabetes in Canada

NCT ID: NCT06786130

This clinical trial is focused on understanding how Type 1 Diabetes (T1D) affects caregivers in Canada. Specifically, it aims to measure the impact of T1D on caregivers' work productivity, their us...

Feasibility of a Tailored Online Self-compassion Intervention

NCT ID: NCT07051005

This clinical trial is testing a new, four-week online program designed to help people with Type 1 or Type 2 diabetes manage the emotional challenges that often come with the condition. The program...

Effect of Inulin Supplementation on Glycaemic Control and Immunological Parameters in Type 1 Diabetes (2024)

NCT ID: NCT07050888

This clinical trial is studying whether taking a supplement called inulin can help adults with type 1 diabetes better manage their blood sugar levels and support their immune system. Inulin is a ty...

Efficacy and Safety of Teplizumab in Japanese Participants With Stage 2 Type 1 Diabetes

NCT ID: NCT06791291

This clinical trial is investigating the effectiveness and safety of a medication called teplizumab in young Japanese individuals with Stage 2 Type 1 Diabetes (T1D). Stage 2 T1D means that a person...

Dapagliflozin Plus Pioglitazone in T1DM

NCT ID: NCT03878459

This clinical trial is studying the effects of a new combination therapy for people with Type 1 Diabetes Mellitus (T1DM). The researchers want to see if adding two medications, dapagliflozin and pi...

Real-world Study on the Effectiveness and Safety of Control-IQ Technology in Teenagers With Type 1 Diabetes Engaging in Regular Physical Activity

NCT ID: NCT06876207

This clinical trial is studying how well the Control-IQ technology helps manage blood sugar levels in teenagers with type 1 diabetes while they are physically active. Researchers believe that this ...

Evaluate Use of Tropocells(R) Autologous Platelet-rich Fibrin (PRF) for Wagner Grade 1 and Grade 2, Mild to Mod Neuroischemic Plantar Diabetic Foot Ulcer Wound Care.

NCT ID: NCT06810726

This clinical trial is studying a treatment called Tropocells Autologous Platelet-rich Fibrin (PRF) to help heal chronic foot ulcers in people with diabetes. Specifically, it is focused on patients...

A Study of GNTI-122 in Adults Recently Diagnosed With T1D

NCT ID: NCT06919354

This clinical trial is studying a new treatment called GNTI-122 for adults who have recently been diagnosed with Type 1 Diabetes (T1D). The goal is to see if this treatment is safe and how it affec...

Feasibility Study of a Behavioral Parent Intervention to Support Self-management in Pediatric Typ 1 Diabetes

NCT ID: NCT06599840

This clinical trial is exploring a new program designed to help parents support their children, aged 9 to 14, who have type 1 diabetes. The goal of the study is to see if this behavioral interventi...

Carb Counting vs. Simplified Qualitative Meal-Size Estimation

NCT ID: NCT06687434

This clinical trial is designed to compare two different methods for managing meals in adolescents with Type 1 Diabetes Mellitus who are starting to use Automated Insulin Delivery (AID) systems. Th...

The Effect of Diabetes M Application Use Versus Conventional Bolus Calculation in Patients With Type 1 Diabetes Mellitus

NCT ID: NCT06974201

A Study of LY3938577 in Healthy Participants and Participants With Type 1 Diabetes Mellitus (T1DM)

NCT ID: NCT06280703

This clinical trial is studying a new drug called LY3938577 to understand how it works in the body, especially for people with Type 1 Diabetes Mellitus (T1DM). The researchers want to find out how ...

InsuLearn Feasibility With Type 1 Diabetes Patients Under MDI Therapy

NCT ID: NCT06411548

This clinical trial, called InsuLearn, is exploring a new way to help adults with Type 1 Diabetes who use multiple daily injections (MDI) of insulin. The goal is to see if a special program called ...

Tirzepatide for the Treatment of Concurrent Type 1 Diabetes and Overweight or Obesity

NCT ID: NCT06180616

This clinical trial is studying a medication called tirzepatide to see if it can help people with Type 1 Diabetes (T1D) who are also overweight or obese. The trial will involve 40 participants who ...